VST BIO Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Monoclonal Antibody to Treat Ischemic Stroke at AHA International Stroke Conference

VST Bio Corporation California

View original content:https://www.prnewswire.co.uk/news-releases/vst-bio-announces-groundbreaking-data-from-non-human-primate-study-evaluating-novel-monoclonal-antibody-to-treat-ischemic-stroke-at-aha-international-stroke-conference-302058324.html